DHHS Pediatric Panel Notice on Nelfinavir FDA-Pfizer Letter
The Department of Health and Human Services' (DHHS) Panel on Pediatric Antiretroviral Therapy & Management has issued a notice with updated recommendations on the use of nelfinavir in pediatric HIV patients.
Full text of the notice is available from AIDSinfo:
DHHS Perinatal Panel Notice on Nelfinavir FDA-Pfizer Letter
The Department of Health and Human Services' (DHHS) Panel on Treatment of HIV-Infected Pregnant Women & Prevention of Perinatal Transmission has issued a notice with updated recommendations on the use of nelfinavir in pregnant HIV patients.
Full text of the notice is available from AIDSinfo: